NO972017D0 - Substituerte tetracykliske azepinderivater som har affinitet for 5-HT2 -reseptorer - Google Patents

Substituerte tetracykliske azepinderivater som har affinitet for 5-HT2 -reseptorer

Info

Publication number: NO972017D0
Authority: NO; Norway
Prior art keywords: receptors; affinity; substituted tetracyclic; azepine derivatives; tetracyclic azepine
Prior art date: 1994-11-02

Application number

NO972017A

Other languages

English (en)

Other versions

NO308035B1 (no

NO972017L (no

Inventor

Victor Karel Sipido

Francisco Javi Fernandez-Gadea

Jose Ignacio Andres-Gil

Theo Frans Meert

Pilar Gil-Lopetegui

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-11-02

Filing date

1997-04-30

Publication date

1997-04-30

1997-04-30 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

1997-04-30 Publication of NO972017D0 publication Critical patent/NO972017D0/no

1997-04-30 Publication of NO972017L publication Critical patent/NO972017L/no

2000-07-10 Publication of NO308035B1 publication Critical patent/NO308035B1/no

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
- C07D223/20—Dibenz [b, e] azepines; Hydrogenated dibenz [b, e] azepines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Heart & Thoracic Surgery (AREA)
Anesthesiology (AREA)
Diabetes (AREA)
Cardiology (AREA)
Child & Adolescent Psychology (AREA)
Addiction (AREA)
Obesity (AREA)
Hospice & Palliative Care (AREA)
Hematology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

NO972017A 1994-11-02 1997-04-30 Substituerte tetracykliske azepinderivater som har affinitet for 5-HT2-reseptorer NO308035B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP94203178		1994-11-02
US08/457,968 US5552399A (en)	1994-11-02	1995-05-31	Substituted tetracyclic azepine derivatives
PCT/EP1995/004196 WO1996014320A1 (en)	1994-11-02	1995-10-25	Substituted tetracyclic azepine derivatives which have affinity for 5-ht2 receptors

Publications (3)

Publication Number	Publication Date
NO972017D0 true NO972017D0 (no)	1997-04-30
NO972017L NO972017L (no)	1997-04-30
NO308035B1 NO308035B1 (no)	2000-07-10

Family

ID=8217337

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO972017A NO308035B1 (no)	1994-11-02	1997-04-30	Substituerte tetracykliske azepinderivater som har affinitet for 5-HT2-reseptorer

Country Status (30)

Country	Link
US (1)	US5552399A (no)
EP (1)	EP0789701B1 (no)
JP (1)	JP3818541B2 (no)
KR (1)	KR100392060B1 (no)
CN (1)	CN1085667C (no)
AR (1)	AR002238A1 (no)
AT (1)	ATE199087T1 (no)
AU (1)	AU704285B2 (no)
BR (1)	BR9509552A (no)
CA (1)	CA2203661A1 (no)
CZ (1)	CZ286945B6 (no)
DE (1)	DE69520070T2 (no)
DK (1)	DK0789701T3 (no)
ES (1)	ES2155898T3 (no)
FI (1)	FI113050B (no)
GR (1)	GR3035680T3 (no)
HR (1)	HRP950537A2 (no)
HU (1)	HUT77408A (no)
IL (1)	IL115819A (no)
MY (1)	MY113325A (no)
NO (1)	NO308035B1 (no)
NZ (1)	NZ295656A (no)
PL (1)	PL183686B1 (no)
PT (1)	PT789701E (no)
RU (1)	RU2163240C2 (no)
SI (1)	SI0789701T1 (no)
TR (1)	TR199501356A2 (no)
TW (1)	TW349950B (no)
WO (1)	WO1996014320A1 (no)
ZA (1)	ZA959215B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ329954A (en) *	1996-04-12	1999-07-29	Janssen Pharmaceutica Nv	Isoxazolidine tetracyclic and tricyclic ring system derivatives and medicaments
UA52778C2 (uk) *	1997-10-10	2003-01-15	Янссен Фармацевтика Н.В.	Галогенозаміщені тетрациклічні похідні тетрагідрофурану, спосіб їх отримання та композиція на їх основі
HRP20020305A8 (en)	2002-04-10	2009-03-31	GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o.	2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
HRP20030885A2 (en) *	2003-11-03	2005-08-31	Pliva-Istra�iva�ki institut d.o.o.	USE OF 2-THIA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYYTEM DISEASES AND DISORDERS
HRP20030953A2 (en) *	2003-11-21	2005-10-31	Pliva-Istra�iva�ki institut d.o.o.	PREPARATION OF 1-AZA-2-OXA-DIBENZO[e,h]AZULENES AND THEIR USE FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
US20110086086A1 (en) *	2005-07-26	2011-04-14	Pfizer Inc	Transdermal system for varenicline
JP2020526592A (ja)	2017-07-13	2020-08-31	トニックスファーマシューティカルズホールディングコーポレーション	シクロベンザプリン類似体及びアミトリプチレン類似体

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AT338799B (de) *	1974-03-02	1977-09-12	Boehringer Sohn Ingelheim	Verfahren zur herstellung neuer substituierter 6-aryl-4h-s-triazolo-(3,4c)-thieno-(2,3e)-1,4-diazepine und ihrer salze
NL7414038A (nl) *	1974-10-28	1976-05-03	Akzo Nv	Nieuwe tetracyclische pyrrolidino derivaten.
DE2647114A1 (de) *	1975-10-21	1977-05-05	Hans Fickler	Vorrichtung zur erzeugung einer laengsbewegung
JPS5572177A (en) *	1978-11-27	1980-05-30	Shionogi & Co Ltd	4,1-benzoxazepine or 4,1-benzothiazepine
IE903557A1 (en) *	1989-10-05	1991-04-10	Sankyo Co	Novel tetracyclic compounds having anti-allergic and¹anti-asthmatic activities, their preparation and use
US5512563A (en) *	1993-07-29	1996-04-30	American Cyanamid Company	Tricyclic benzazepine vasopressin antagonists

1995
- 1995-05-31 US US08/457,968 patent/US5552399A/en not_active Expired - Fee Related
- 1995-10-20 TW TW084111063A patent/TW349950B/zh active
- 1995-10-25 SI SI9530482T patent/SI0789701T1/xx unknown
- 1995-10-25 PT PT95937006T patent/PT789701E/pt unknown
- 1995-10-25 CN CN95195969A patent/CN1085667C/zh not_active Expired - Fee Related
- 1995-10-25 AU AU39249/95A patent/AU704285B2/en not_active Ceased
- 1995-10-25 BR BR9509552A patent/BR9509552A/pt not_active IP Right Cessation
- 1995-10-25 KR KR1019970702800A patent/KR100392060B1/ko not_active Expired - Fee Related
- 1995-10-25 DK DK95937006T patent/DK0789701T3/da active
- 1995-10-25 NZ NZ295656A patent/NZ295656A/xx unknown
- 1995-10-25 ES ES95937006T patent/ES2155898T3/es not_active Expired - Lifetime
- 1995-10-25 RU RU97108691/04A patent/RU2163240C2/ru not_active IP Right Cessation
- 1995-10-25 CZ CZ19971323A patent/CZ286945B6/cs not_active IP Right Cessation
- 1995-10-25 WO PCT/EP1995/004196 patent/WO1996014320A1/en not_active Ceased
- 1995-10-25 DE DE69520070T patent/DE69520070T2/de not_active Expired - Fee Related
- 1995-10-25 PL PL95319939A patent/PL183686B1/pl not_active IP Right Cessation
- 1995-10-25 JP JP51500996A patent/JP3818541B2/ja not_active Expired - Fee Related
- 1995-10-25 HU HU9702298A patent/HUT77408A/hu unknown
- 1995-10-25 EP EP95937006A patent/EP0789701B1/en not_active Expired - Lifetime
- 1995-10-25 CA CA002203661A patent/CA2203661A1/en not_active Abandoned
- 1995-10-25 AT AT95937006T patent/ATE199087T1/de not_active IP Right Cessation
- 1995-10-31 ZA ZA959215A patent/ZA959215B/xx unknown
- 1995-10-31 HR HR08/457,968A patent/HRP950537A2/hr not_active Application Discontinuation
- 1995-10-31 IL IL11581995A patent/IL115819A/en not_active IP Right Cessation
- 1995-11-01 AR ARP950100010A patent/AR002238A1/es unknown
- 1995-11-02 MY MYPI95003312A patent/MY113325A/en unknown
- 1995-11-02 TR TR95/01356A patent/TR199501356A2/xx unknown
1997
- 1997-04-30 NO NO972017A patent/NO308035B1/no unknown
- 1997-04-30 FI FI971854A patent/FI113050B/fi not_active IP Right Cessation
2001
- 2001-03-30 GR GR20010400530T patent/GR3035680T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
ZA959215B (en)	1997-04-30
EP0789701A1 (en)	1997-08-20
NO308035B1 (no)	2000-07-10
FI971854A7 (fi)	1997-04-30
DE69520070D1 (de)	2001-03-15
CZ286945B6 (en)	2000-08-16
GR3035680T3 (en)	2001-06-29
PL319939A1 (en)	1997-09-01
PL183686B1 (pl)	2002-06-28
CA2203661A1 (en)	1996-05-17
ES2155898T3 (es)	2001-06-01
AU704285B2 (en)	1999-04-15
CN1085667C (zh)	2002-05-29
PT789701E (pt)	2001-07-31
TW349950B (en)	1999-01-11
NZ295656A (en)	1998-10-28
HUT77408A (hu)	1998-04-28
HRP950537A2 (en)	1997-08-31
AR002238A1 (es)	1998-03-11
IL115819A0 (en)	1996-01-19
FI971854A0 (fi)	1997-04-30
MY113325A (en)	2002-01-31
RU2163240C2 (ru)	2001-02-20
CZ132397A3 (cs)	1998-01-14
CN1162313A (zh)	1997-10-15
JPH10508308A (ja)	1998-08-18
KR100392060B1 (ko)	2003-11-28
FI113050B (fi)	2004-02-27
WO1996014320A1 (en)	1996-05-17
JP3818541B2 (ja)	2006-09-06
IL115819A (en)	1998-10-30
EP0789701B1 (en)	2001-02-07
AU3924995A (en)	1996-05-31
MX9703255A (es)	1997-07-31
TR199501356A2 (tr)	1996-06-21
DK0789701T3 (da)	2001-06-18
US5552399A (en)	1996-09-03
DE69520070T2 (de)	2001-09-13
ATE199087T1 (de)	2001-02-15
NO972017L (no)	1997-04-30
BR9509552A (pt)	1997-09-16
SI0789701T1 (en)	2001-08-31

Publication	Publication Date	Title
FI973205L (fi)	1997-10-01	Indolijohdannaisia 5-HT-reseptoriantagonisteina
NO982589L (no)	1998-08-03	3-pyrazol-karboksamid-derivater med cannabinoid reseptor-affinitet
NO20010603D0 (no)	2001-02-05	2-substituert-1-piperidylbenzimidazol forbindelser som ORL 1- reseptor agonister
DK0856001T3 (da)	2002-12-30	Pyrimidinderivater som 5-HT2C-receptor-antagonister
FI943941L (fi)	1994-10-26	CCK-reseptoriantagonisteina käyttökelpoiset bentsodiatsepiinijohdannaiset
NO304693B1 (no)	1999-02-01	Kinoksalinderivater med affinitet for quisqualatreseptorer
DK0708105T3 (da)	1999-08-23	5-HT4-receptoragonister
NO974043L (no)	1997-11-03	Indolderivater som EAA-antagonister
AU2314195A (en)	1995-11-29	Benzofuran derivatives as d4 receptor antagonists
NO960237L (no)	1996-03-19	1,5-Benzodiazepinderivater anvendelige som CCK - eller gastrinantagonister
NO985970D0 (no)	1998-12-18	Indolinderivater anvendelige som 5_HT-2C-reseptor-antagonister
NO972017L (no)	1997-04-30	Substituerte tetracykliske azepinderivater som har affinitet for 5-HT2 -reseptorer
FI951798A0 (fi)	1995-04-13	Bentsofuraanijohdannaiset 5-HT1-kaltaisina reseptoriantagonisteina
KR970013921U (ko)	1997-04-28	건축용 다용도 브라켓
DK0836606T3 (da)	2000-11-20	Kondenserede thiazolderivater, der har 5-HT-receptoraffinitet
NO985972D0 (no)	1998-12-18	Indolinderivater anvendelige som 5-HT-2C reseptorantagonister
NO20006041D0 (no)	2000-11-29	N-Benzodioksanylmetyl-1-piperidyl-metylamin-forbindelser med affinitet for 5-HT-reseptorer
FI943872A0 (fi)	1994-08-23	2,6-metano-2H-kinditsiinijohdannainen 5-HT3-reseptoriantagonistina
NO963775D0 (no)	1996-09-09	Indol-derivater som CCK-reseptorantagonister